We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AstraZeneca Pays Texas $110M For Off-Label Marketing Of Seroquel, Crestor

(August 8, 2018, 1:23 PM EDT) -- AUSTIN, Texas — AstraZeneca LP has agreed to pay $110 to resolve two Texas state Medicaid fraud lawsuits for the wrongful promotion of the antipsychotic drug Seroquel and the statin drug...
To view the full article, register now.